Trastuzumab deruxtecan is approved for HR-positive, HER2-low/ultralow metastatic breast cancer post-endocrine therapy, based on DESTINY-Breast06 trial results. The trial showed a 36% reduction in ...

In the HER2-low population, treatment with trastuzumab deruxtecan reduced the risk of disease progression or death by 38% compared with chemotherapy. The Food and Drug Administration (FDA ...

From budget enthusiast builds to pro setups, these are our picks of the most reliable 3D printers you can buy. James has been writing about technology for years but has loved it since the early 90s.

3D printing is a fun, creative hobby. Thankfully, a good 3D printer no longer has to be a major splurge. Here are our expert picks for the best budget 3D printers on the market. James has been ...

Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up ...

En la era digital, transformar una foto 2D en una espectacular imagen 3D se convirtió en una de las revoluciones más interesantes de la industria tanto del diseño, como del entretenimiento y ta ...

Impact of combined resection of pancreas on long-term survival in patients with gastric cancer. Preliminary results of the ALTER-E009 study: Efficacy and safety of anlotinib combined with radiotherapy ...

The world’s first fully 3D-printed microscope can be made in a few hours and for a fraction of the cost of traditional ones. “It’s not just enabling, it’s empowering,” says Gail ...

And that story is still being written. Now, Geyer and his colleagues are investigating a promising new antibody-drug candidate called trastuzumab deruxtecan, or T-DXd, for certain groups of ...

And that story is still being written. Now, Geyer and his colleagues are investigating a promising new antibody-drug candidate called trastuzumab deruxtecan, or T-DXd, for certain groups of ...